Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Andrew M. Roecker"'
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 4 (2010)
Nelarabine is a nucleoside analog indicated for the treatment of adult and pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LBL) that is refractory or has relapsed after treatment with at least t
Externí odkaz:
https://doaj.org/article/03f14c3373e842ddb515f3ed61e6e198
Publikováno v:
The Annals of pharmacotherapy. 50(8)
Objective: Summarize data on the pathophysiology, treatment, and prevention options for non–AIDS immunocompromised patients who have Pneumocystis jirovecii pneumonia (PJP); review the epidemiology of patients presenting with PJP; and discuss the fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4934c1c63eb0b9f1ddb262aae24fcbf
https://pubmed.ncbi.nlm.nih.gov/27242349
https://pubmed.ncbi.nlm.nih.gov/27242349
Publikováno v:
Future Oncology. 2:441-448
Nelarabine is a nucleoside analog prodrug of 9-β-D-arabinofuranosylguanine. Nelarabine is indicated for the treatment of adult and pediatric patients with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma whose disease has not res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a84d18c324d6aa04b9f0e11323996f4
https://doi.org/10.2217/14796694.2.4.441
https://doi.org/10.2217/14796694.2.4.441
Autor:
Scott D Pope, Andrew M. Roecker
Publikováno v:
Expert opinion on pharmacotherapy. 9(10)
Dalbavancin is a lipoglycopeptide antibacterial agent with in vitro and in vivo activity against a number of Gram-positive organisms, including some with multidrug resistance. This is a review of the available literature explaining the pertinent info
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e83d0ada819185a3cf822fa59f2173d3
https://pubmed.ncbi.nlm.nih.gov/18570607
https://pubmed.ncbi.nlm.nih.gov/18570607